Topics

SARS-CoV-2 spike protein

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
‘Toxic Shot’: Yale Epidemiologist Discusses Book Blasting COVID Vaccines
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
A Potential Role of the Spike Protein in Neurodegenerative Diseases: A Narrative Review
A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 Messenger Ribonucleic Acid (mRNA) Biologicals
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Adverse effects of COVID-19 vaccines and measures to prevent them
Affidavit of LTC. Theresa Long M.D. in Support of a Motion for a Preliminary Injunction Order
All Cause Mortality and COVID-19 Injections: Evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”
Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit?
Amyloidogenesis of SARS-CoV-2 Spike Protein
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Antiviral treatments [Molnupiravir] lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2
Autoimmune and Neoplastic Outcomes After the mRNA Vaccination: The Role of T Regulatory Cell Responses
Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature
Be aware of SARS-CoV-2 spike protein: There is more than meets the eye
Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure
Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 - A Multidisciplinary Perspective
Chemical-physical criticality and toxicological potential of lipid nanomaterials contained in a COVID-19 mRNA vaccine
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination
Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes
Comirnaty (COVID-19 mRNA Vaccine) Risk Management Plan
Comirnaty Facts: Mechanisms of action and damage potential
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures
Could the Spike Protein Derived from mRNA Vaccines Negatively Impact Beneficial Bacteria in the Gut?
COVID Injections: Unveiling the Mechanisms of Harm
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
COVID-19 mRNA “vaccine” harms research collection
COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
COVID-19 Vaccine: Critical Questions with Complicated Answers
COVID-19 vaccines – An Australian Review
Critical appraisal of multidrug therapy in the ambulatory management of patients with COVID-19 and hypoxemia
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children
Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms
Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease
908